id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0008-0035,FDA,FDA-2009-D-0008,"Citizen Petitions and Petitions for Stay of Action Subject to the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Notice of Availability,2019-09-19T04:00:00Z,2019,9,2019-09-19T04:00:00Z,,2025-03-20T17:18:30Z,2019-20312,0,0,0900006483f9b3a1
FDA-2009-D-0008-0036,FDA,FDA-2009-D-0008,"Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act:  Guidance for Industry",Other,Guidance,2019-09-18T04:00:00Z,2019,9,2019-09-18T04:00:00Z,,2025-11-14T23:58:27Z,,1,0,0900006483fcdaae
FDA-2009-D-0008-0037,FDA,FDA-2009-D-0008,Evaluation of Internal Standard Responses During Chromatographic Bioanalysis Questions and Answers,Other,Guidance,2019-09-04T04:00:00Z,2019,9,2025-03-20T04:00:00Z,,2025-03-20T17:25:25Z,,1,0,090000648464ea51